Northwest & Ethical Investments L.P. Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Northwest & Ethical Investments L.P. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,741 shares of the medical equipment provider’s stock after buying an additional 5,288 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Intuitive Surgical were worth $7,733,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of ISRG. Castle Hook Partners LP acquired a new stake in Intuitive Surgical during the 3rd quarter worth $53,126,000. Public Sector Pension Investment Board raised its position in Intuitive Surgical by 8.3% during the third quarter. Public Sector Pension Investment Board now owns 172,373 shares of the medical equipment provider’s stock worth $84,682,000 after acquiring an additional 13,150 shares during the last quarter. Fiduciary Trust Co boosted its stake in shares of Intuitive Surgical by 5.0% during the third quarter. Fiduciary Trust Co now owns 10,175 shares of the medical equipment provider’s stock valued at $4,999,000 after acquiring an additional 485 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 150,533 shares of the medical equipment provider’s stock worth $73,952,000 after purchasing an additional 2,556 shares during the period. Finally, MayTech Global Investments LLC raised its stake in Intuitive Surgical by 17.0% during the third quarter. MayTech Global Investments LLC now owns 64,719 shares of the medical equipment provider’s stock worth $31,795,000 after purchasing an additional 9,380 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,459 shares of company stock valued at $26,080,251 in the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $538.55 on Friday. The company’s 50-day moving average is $508.91 and its 200-day moving average is $467.29. The firm has a market capitalization of $191.82 billion, a PE ratio of 86.58, a P/E/G ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Stifel Nicolaus upped their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $526.06.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.